A critical review of microplastics toxicity and potential adverse outcome pathway in human gastrointestinal tract following oral exposure

Toxicol Lett. 2023 Aug 15:385:51-60. doi: 10.1016/j.toxlet.2023.08.011. Epub 2023 Sep 1.

Abstract

Microplastics (MPs) are typically produced via environmental degradation of larger plastics, where they enter the human food chain. MPs are complex materials containing chemical and physical characteristics that can potentially affect their hazard and exposure. These physical properties can be altered by environmental exposure potentially altering any risk assessment conducted on the primary material. We conducted a literature review using an Adverse Outcome Pathway (AOP)-based approach from Molecular Initiating Event (MIE) to cell effect event to identify multiple knowledge gaps that affect MPs hazard assessment. There is some convergence of key biological events but could relate to most lying along well-established biological effector pathways such as apoptosis which can respond to many MIEs. In contrast, MIEs of chemicals will be via protein interaction. As MPs may occur in the lumen of the alimentary canal for example to the mucus, therefore, not requiring translocation of MPs across the epithelial membrane. At the other end of the AOP, currently it is not possible to identify a single adverse outcome at the organ level. This work did establish a clear need to understand both external and internal exposure (resulting from translocation) and develop hazard data at both levels to inform on risk assessments.

Keywords: AOP; Ingestion; Intestinal; Particles; Polymer.

Publication types

  • Review

MeSH terms

  • Adverse Outcome Pathways*
  • Gastrointestinal Tract
  • Humans
  • Microplastics / toxicity
  • Plastics
  • Risk Assessment
  • Translocation, Genetic

Substances

  • Microplastics
  • Plastics